Medartis
Medartis AG, headquartered in Switzerland (CH), is a leading player in the medical device industry, specialising in innovative solutions for the treatment of bone fractures and deformities. Founded in 1997, the company has established a strong presence in Europe, Asia, and the Americas, focusing on advanced surgical techniques and high-quality implants. Medartis is renowned for its unique product offerings, including the patented locking plate systems and comprehensive range of surgical instruments designed for orthopaedic and trauma surgery. These products are distinguished by their precision engineering and commitment to enhancing patient outcomes. With a solid market position, Medartis has achieved significant milestones, including numerous regulatory approvals and partnerships with healthcare professionals worldwide, solidifying its reputation as a trusted provider in the orthopaedic sector.
DitchCarbon Score
How does Medartis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medartis's score of 36 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medartis's reported carbon emissions
In 2023, Medartis reported total carbon emissions of approximately 6,857,000 kg CO2e globally. This figure includes 857,000 kg CO2e from Scope 1 emissions, which primarily arise from stationary and mobile combustion, and 604,000 kg CO2e from Scope 2 emissions, mainly from purchased electricity. Notably, Scope 3 emissions accounted for a significant portion, with 2,498,000 kg CO2e attributed to purchased goods and services, alongside other categories such as business travel and employee commute. In 2022, Medartis's total emissions were about 1,626,000 kg CO2e for Scope 1 and 2 combined, indicating a substantial increase in emissions in 2023. The company has committed to near-term reduction targets, although specific numerical goals have not been disclosed. Medartis is not currently committed to a net-zero target. The company operates within the healthcare equipment and supplies sector and is headquartered in Switzerland (CH). Medartis's climate commitments reflect an awareness of the need for sustainability in the healthcare industry, although further details on specific reduction initiatives or long-term strategies remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 795,000 | 000,000 |
| Scope 2 | 831,000 | 000,000 |
| Scope 3 | 689,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medartis is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
